美敦力宣布拆分糖尿病业务

环球市场播报2025-05-21

医疗设备制造商美敦力（Medtronic）周三宣布，计划将其胰岛素泵及其他可穿戴设备为主的糖尿病业务剥离为独立公司，同时发布的2026年调整后利润预测低于市场预期。　　该业务部门近年来因质量管理问题和部分设备的网络安全隐患遭遇监管审查，持续表现不佳。　　此次拆分将使美敦力更专注于心脏设备等盈利能力更强的业务板块——后者目前是其最大收入来源。　　新公司将由现任美敦力糖尿病业务总裁Que ...

网页链接

免责声明：本文观点仅代表作者个人观点，不构成本平台的投资建议，本平台不对文章信息准确性、完整性和及时性做出任何保证，亦不对因使用或信赖文章信息引发的任何损失承担责任。

精彩评论

我们需要你的真知灼见来填补这片空白

发表看法

{"i18n":{"language":"zh_CN"},"isChannel":false,"data":{"share":"https://www.laohu8.com/m/news/2537931989?lang=zh_CN&edition=full","thumbnail":"","is_english":false,"pubTime":"2025-05-21 22:20","share_image_url":"https://static.laohu8.com/b0d1b7e8843deea78cc308b15114de44","id":"2537931989","market":"sh","top_or_hot":-1,"title":"美敦力宣布拆分糖尿病业务","media":"环球市场播报","content":"<div>\n<p>医疗设备制造商美敦力（Medtronic）周三宣布，计划将其胰岛素泵及其他可穿戴设备为主的糖尿病业务剥离为独立公司，同时发布的2026年调整后利润预测低于市场预期。\n\n　　该业务部门近年来因质量管理问题和部分设备的网络安全隐患遭遇监管审查，持续表现不佳。\n　　此次拆分将使美敦力更专注于心脏设备等盈利能力更强的业务板块——后者目前是其最大收入来源。\n　　新公司将由现任美敦力糖尿病业务总裁Que ...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2025-05-21/doc-inexiyix0393540.shtml\">网页链接</a>\n\n</div>\n","source":"sina","html":"<!DOCTYPE html>\n<html>\n<head>\n<meta http-equiv=\"Content-Type\" content=\"text/html; charset=utf-8\" />\n<meta name=\"viewport\" content=\"width=device-width,initial-scale=1.0,minimum-scale=1.0,maximum-scale=1.0,user-scalable=no\"/>\n<meta name=\"format-detection\" content=\"telephone=no,email=no,address=no\" />\n<title>美敦力宣布拆分糖尿病业务</title>\n<style type=\"text/css\">\na,abbr,acronym,address,applet,article,aside,audio,b,big,blockquote,body,canvas,caption,center,cite,code,dd,del,details,dfn,div,dl,dt,\nem,embed,fieldset,figcaption,figure,footer,form,h1,h2,h3,h4,h5,h6,header,hgroup,html,i,iframe,img,ins,kbd,label,legend,li,mark,menu,nav,\nobject,ol,output,p,pre,q,ruby,s,samp,section,small,span,strike,strong,sub,summary,sup,table,tbody,td,tfoot,th,thead,time,tr,tt,u,ul,var,video{ font:inherit;margin:0;padding:0;vertical-align:baseline;border:0 }\nbody{ font-size:16px; line-height:1.5; color:#999; background:transparent; }\n.wrapper{ overflow:hidden;word-break:break-all;padding:10px; }\nh1,h2{ font-weight:normal; line-height:1.35; margin-bottom:.6em; }\nh3,h4,h5,h6{ line-height:1.35; margin-bottom:1em; }\nh1{ font-size:24px; }\nh2{ font-size:20px; }\nh3{ font-size:18px; }\nh4{ font-size:16px; }\nh5{ font-size:14px; }\nh6{ font-size:12px; }\np,ul,ol,blockquote,dl,table{ margin:1.2em 0; }\nul,ol{ margin-left:2em; }\nul{ list-style:disc; }\nol{ list-style:decimal; }\nli,li p{ margin:10px 0;}\nimg{ max-width:100%;display:block;margin:0 auto 1em; }\nblockquote{ color:#B5B2B1; border-left:3px solid #aaa; padding:1em; }\nstrong,b{font-weight:bold;}\nem,i{font-style:italic;}\ntable{ width:100%;border-collapse:collapse;border-spacing:1px;margin:1em 0;font-size:.9em; }\nth,td{ padding:5px;text-align:left;border:1px solid #aaa; }\nth{ font-weight:bold;background:#5d5d5d; }\n.symbol-link{font-weight:bold;}\n/* header{ border-bottom:1px solid #494756; } */\n.title{ margin:0 0 8px;line-height:1.3;color:#ddd; }\n.meta {color:#5e5c6d;font-size:13px;margin:0 0 .5em; }\na{text-decoration:none; color:#2a4b87;}\n.meta .head { display: inline-block; overflow: hidden}\n.head .h-thumb { width: 30px; height: 30px; margin: 0; padding: 0; border-radius: 50%; float: left;}\n.head .h-content { margin: 0; padding: 0 0 0 9px; float: left;}\n.head .h-name {font-size: 13px; color: #eee; margin: 0;}\n.head .h-time {font-size: 11px; color: #7E829C; margin: 0;line-height: 11px;}\n.small {font-size: 12.5px; display: inline-block; transform: scale(0.9); -webkit-transform: scale(0.9); transform-origin: left; -webkit-transform-origin: left;}\n.smaller {font-size: 12.5px; display: inline-block; transform: scale(0.8); -webkit-transform: scale(0.8); transform-origin: left; -webkit-transform-origin: left;}\n.bt-text {font-size: 12px;margin: 1.5em 0 0 0}\n.bt-text p {margin: 0}\n</style>\n</head>\n<body>\n<div class=\"wrapper\">\n<header>\n<h2 class=\"title\">\n美敦力宣布拆分糖尿病业务\n</h2>\n\n<h4 class=\"meta\">\n\n\n2025-05-21 22:20 北京时间&nbsp;&nbsp;&nbsp;<a href=https://finance.sina.com.cn/stock/usstock/c/2025-05-21/doc-inexiyix0393540.shtml><strong>环球市场播报</strong></a>\n\n\n</h4>\n\n</header>\n<article>\n<div>\n<p>医疗设备制造商美敦力（Medtronic）周三宣布，计划将其胰岛素泵及其他可穿戴设备为主的糖尿病业务剥离为独立公司，同时发布的2026年调整后利润预测低于市场预期。\n\n　　该业务部门近年来因质量管理问题和部分设备的网络安全隐患遭遇监管审查，持续表现不佳。\n　　此次拆分将使美敦力更专注于心脏设备等盈利能力更强的业务板块——后者目前是其最大收入来源。\n　　新公司将由现任美敦力糖尿病业务总裁Que ...</p>\n\n<a href=\"https://finance.sina.com.cn/stock/usstock/c/2025-05-21/doc-inexiyix0393540.shtml\">网页链接</a>\n\n</div>\n\n\n</article>\n</div>\n</body>\n</html>\n","isBrief":false,"type":0,"news_type":1,"symbol":"LU0158827948.USD","symbol_name":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","start_time":0,"source_url":"https://finance.sina.com.cn/stock/usstock/c/2025-05-21/doc-inexiyix0393540.shtml","article_id":"2537931989","we_media_id":null,"thumbnails":[],"rights":null,"url":"https://stock-news.laohu8.com/highlight/detail?id=2537931989","pubTimestamp":1747837200,"columns":[],"sourceInfo":{"source_id":"sina","name":"sina"},"weMediaInfo":null,"summary":"医疗设备制造商美敦力周三宣布，计划将其胰岛素泵及其他可穿戴设备为主的糖尿病业务剥离为独立公司，同时发布的2026年调整后利润预测低于市场预期。　　此次拆分将使美敦力更专注于心脏设备等盈利能力更强的业务板块——后者目前是其最大收入来源。　　新公司将由现任美敦力糖尿病业务总裁Que Dallara执掌，预计将纳入约8000名员工，总部设于加利福尼亚州诺斯里奇市。美敦力预计此次拆分将立即提升公司整体利润率并增厚利润。","collect":0,"end_time":0,"defaultTopTitle":"sina.com.cn","property":[],"viewcount":null,"language":"zh","relate_stocks":{"LU0158827948.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"A\" (USD) INC","LU1989764664.SGD":"CPR Invest - Global Disruptive Opportunities A2 Acc SGD-H","LU2089283258.USD":"安联环球可持续基金Cl AM Dis","LU1989764748.USD":"东方汇理环球颠覆性机遇A2 Acc","LU2111349929.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (HKD) INC","LU1116320901.HKD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (HKD) INC","LU0265550946.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A5\" (USD) INC","LU0976567544.SGD":"FTIF - Templeton Global Income A Mdis SGD-H1","BK4585":"ETF&股票定投概念","LU2089984988.USD":"MANULIFE GF HEALTHCARE \"AA\" (USD) ACC","BK4533":"AQR资本管理(全球第二大对冲基金)","LU2271345857.HKD":"ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (HKD) ACC","IE000M9KFDE8.USD":"NEUBERGER BERMAN US LARGE CAP VALUE \"A\" (USD) ACC","LU0072461881.USD":"BGF US BASIC VALUE \"A2\" ACC","IE00BQXX3F31.USD":"GUINNESS GLOBAL INNOVATORS \"C\" (USD) ACC","LU0208291251.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) INC","BK4566":"资本集团","LU1983299246.USD":"SCHRODER ISF HEALTHCARE INNOVATION \"A\" (USD) ACC","LU0158827781.USD":" ALLIANZ GLOBAL SUSTAINABILITY \"AT\" (USD) ACC","MDT":"美敦力","LU0070302665.USD":"FRANKLIN MUTUAL U.S. VALUE \"A\" (USD) ACC","LU0265550359.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A2\" (USD) ACC","IE00BQXX3C00.GBP":"GUINNESS GLOBAL INNOVATORS \"C\" (GBP) ACC","LU2089284900.SGD":"Allianz Global Sustainability Cl AM Dis H2-SGD","BK4082":"医疗保健设备","IE00BQXX3D17.EUR":"GUINNESS GLOBAL INNOVATORS \"C\" (EUR) ACC","LU1116320737.USD":"BGF SYSTEMATIC GLOBAL ENHANCED EQUITY YIELD \"A6\" (USD) INC","LU1989771016.USD":"东方汇理环球老龄化投资基金 A2 Acc","IE00B3T34201.USD":"BNY MELLON GLOBAL EQUITY INCOME \"B\" (USD) INC","LU1571399168.USD":"ALLSPRING GLOBAL LONG/SHORT EQUITY \"IP\" (USD) ACC","LU1291159041.SGD":"CPR Invest - Global Silver Age A2 Acc SGD-H","BK4588":"碎股","LU2023251221.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AM\" (USD) INC","LU2468319806.SGD":"MANULIFE GF HEALTHCARE \"AA\" (SGDHDG) ACC","LU0211326839.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) INC","LU0320765489.SGD":"FTIF - Franklin Mutual US Value A Acc SGD","LU2028103732.USD":"ALLIANZ GLOBAL SUSTAINABILITY \"AMG\" (USD) INC","LU0162691827.USD":"BGF US BASIC VALUE \"A4\" INC","LU0496365809.HKD":"TEMPLETON GLOBAL INCOME \"A\" (HKD) INC (Q)","IE00BFXG1179.USD":"BNY MELLON U.S. EQUITY INCOME \"B\" (USD) INC","LU0211326755.USD":"TEMPLETON GLOBAL INCOME \"A\" (USD) ACC","LU0211331839.USD":"FRANKLIN MUTUAL GLB DISCOVERY \"A\" (USD) ACC"},"translate_title":"Medtronic announces split of diabetes business","themeId":null,"isJumpTheme":false,"ttsUrl":null,"symbols_score_info":{"MDT":1},"content_text":"医疗设备制造商美敦力（Medtronic）周三宣布，计划将其胰岛素泵及其他可穿戴设备为主的糖尿病业务剥离为独立公司，同时发布的2026年调整后利润预测低于市场预期。\n\n　　该业务部门近年来因质量管理问题和部分设备的网络安全隐患遭遇监管审查，持续表现不佳。\n　　此次拆分将使美敦力更专注于心脏设备等盈利能力更强的业务板块——后者目前是其最大收入来源。\n　　新公司将由现任美敦力糖尿病业务总裁Que Dallara执掌，预计将纳入约8000名员工，总部设于加利福尼亚州诺斯里奇市。美敦力预计此次拆分将立即提升公司整体利润率并增厚利润。\n　　公司声明指出，与其他医疗设备主要面向机构客户不同，糖尿病设备主要通过直销渠道面向终端消费者，需要差异化的商业与生产策略。拆分计划拟在未来18个月内通过资本市场交易完成，优先考虑采用IPO后分拆的方案。\n　　摩根大通分析师Robbie Marcus表示：“无论是美敦力糖尿病业务难以维持当前中高个位数的有机增长……抑或该业务已无法为公司创造战略价值……我们对这则消息持审慎态度。”\n\n\n\n海量资讯、精准解读，尽在新浪财经APP\n\n责任编辑：张俊 SF065","kind":"news","is_publish_news":true,"is_publish_highlight":false,"is_publish_live":false,"is_publish_wemedia":null,"editions":null,"column":"","sentiment":"1","news_tag":"corporation","news_rank":0,"symbols":[],"gpt_button":1,"need_auth":false,"code":"91000000","status":"200"},"commentList":[],"isCommentEnd":true,"newsSizeData":{"likeSize":0,"commentSize":0,"repostSize":0,"favoriteSize":0,"likeStatus":false,"favoriteStatus":false},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"deviceId":"web-server-community-laohu8-v3","version":"4.35.13","shortVersion":"4.35.13","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"href":"/m/news/2537931989","isCrawlerRequest":true}